Upadacitinib Recommended for Nonradiographic AxSpA in Europe

The Janus kinase inhibitor is already approved for the treatment of active ankylosing spondylitis in the European Union.

Related Keywords

United States ,Neil Gallagher ,European Alliance Of Associations ,European Union ,European Commission ,Assessment Of Spondyloarthritis International Society ,European Medicines Agency ,Medicinal Products ,Human Use ,European Alliance ,Spondyloarthritis International Society ,Ulcerative Colitis ,Europe ,European ,Activism ,Activist ,Social Issues ,Internship ,Interns ,Rheumatoid Arthritis ,A ,